Daunorubicin hydrochloride is authorized for use as a remission induction treatment with additional medicines to treat:
Use in Cancer Treatment
Brand Name in the United States (s) Cerubidine
Adults and children with acute lymphoblastic leukemia.
Adults with acute myeloid leukemia.
It’s also under research for use in the treatment of other cancers.
An anthracycline antineoplastic antibiotic having therapeutic properties similar to doxorubicin’s hydrochloride salt. Daunorubicin causes cytotoxicity by interacting with DNA via topoisomerase, limiting DNA replication and repair, as well as RNA and protein synthesis.
Daunorubicin Hydrochloride – MedlinePlus Information
A summary of key facts regarding this medication in layman’s terms, which may contain the following:
- Cautions about this medicine
- What is the use and how?
- Whom should you consult before taking it?
- What you should know about it before using it?
- Other drugs that might interact with it, and possible negative effects
Drugs are frequently under research to see whether they can assist treat or prevent conditions other than those already prevalent. This patient information leaflet covers uses which have been under authorization. Much of the material, though, might also apply to authorized uses that are under research.